
Medline Inc.
MDLNNASDAQHealthcareMedical - Instruments & Supplies
Previous close
$34.26
+$1.68 · +5.16%
MDLN company overview
Regular session · ET · Market data may be delayed.
GoAI snapshot
AI-powered factor overview
GoAI score
Hold
Wait — insufficient conviction to act
Valuation
76
Undervalued
Momentum
41
Neutral
Sentiment
49
Mixed
Risk resilience
62
Moderate Risk
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
AI-generated, informational only, and not investment advice.
Company profile
Company websiteMedline Inc. is a global manufacturer of medical and surgical products, catering to a broad spectrum of healthcare providers. Their clientele includes hospitals, surgical centers, physician practices, post-acute care facilities, and nursing homes, both domestically and worldwide. The company's operations are divided into two primary divisions: the Medline Brand and Supply Chain Solutions. The Medline Brand division focuses on the production and sourcing of its proprietary medical products, categorized into three key areas: Within Frontline Care, Medline provides a wide array of patient-facing medical and surgical items. This encompasses essentials like wound care treatments, examination gloves, skin and incontinence products, sanitation supplies, various textiles, hand sanitizers, durable medical equipment (DME), patient-specific plastic goods, and decolonization and infection control solutions. The Surgical Solutions category delivers comprehensive product lines for operating rooms and perioperative settings. Offerings range from surgical procedure trays, drapes, and gowns to personal protective equipment (PPE), sterile wraps, various surgical instruments, specialized surgeon's gloves, complete procedure kits, and orthopedic implants. Finally, Laboratory and Diagnostics supplies critical solutions for clinical testing and analysis. This includes point-of-care testing devices, analytical instruments, laboratory consumables, advanced diagnostic equipment, vital signs monitoring systems, and products for anatomic pathology and phlebotomy. The Supply Chain Solutions segment is responsible for sourcing and distributing a diverse portfolio of third-party products, including those from well-known national brands. Beyond distribution, this segment offers comprehensive logistics and supply chain optimization services to clients both domestically and internationally. These optimization services encompass strategic consulting, outsourced management of warehousing and technology, specialized "put-away-ready" packaging, third-party logistics (3PL), inventory rationalization strategies, and efficient route planning. Established in 1966, Medline Inc. maintains its headquarters in Northfield, Illinois.
- Industry
- Medical - Instruments & Supplies
- Sector
- Healthcare
- Headquarters
- US
- CEO
- James Boyle
- Listed since
- Dec 17, 2025
- Employees
- 45,000
Market position
Day range
Current $34.26
52-week range
Current $34.26
- Open
- $32.51
- Previous close
- $32.58
- Volume
- 6.99M
- 0.79× average
- Average volume
- 8.8M
- Average daily volume
- Market cap
- 28.97B USD
- Beta
- -0.41
- Market reference 1
- 50-day average
- $37.9855
- -9.81% below average
- 200-day average
- $41.3586
- -17.16% below average
Financials
Financial snapshot
Latest / TTMValuation & yield
- P/E (TTM)
- 39.84×
- P/B (TTM)
- 2.54×
- P/S (TTM)
- 0.97×
- Dividend yield
- 0.00%
Profitability & efficiency
- Gross margin
- 25.02%
- Operating margin
- 6.07%
- Net margin
- 2.31%
Financial health
- Debt / equity
- 1.09×
Financial statements
Margin trends
Profitability as a percentage of reported revenue.
Income trends
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | 28.43B USD | 25.51B USD | 23.23B USD | 21.45B USD |
| Cost of goods sold | 20.91B USD | 19.22B USD | 18.01B USD | 16.89B USD |
| Gross profit | 7.52B USD | 6.29B USD | 5.22B USD | 4.56B USD |
| Research and development | — | 67M USD | 60M USD | 58M USD |
| Selling, general, and administrative | 4.52B USD | 4.04B USD | 3.81B USD | 3.62B USD |
| Operating expenses | 5.31B USD | 4.07B USD | 3.78B USD | 3.69B USD |
| Interest income | — | 280M USD | 237M USD | 27M USD |
| Interest expense | 812M USD | 1.31B USD | 1.38B USD | 911M USD |
| Depreciation and amortization | 704M USD | 977M USD | 951M USD | 933M USD |
| Operating income | 2.21B USD | 2.23B USD | 1.44B USD | 870M USD |
| Net income | 1.16B USD | 1.2B USD | 234M USD | −25M USD |
Company facts updated Aug 24, 2026.
Earnings
- EPS beat rate
- 67%
- 2 beats, 1 miss, 0 met estimates
- Average EPS surprise
- +16.01%
- 3 comparable reports
- Latest EPS result
- 0.5
- Estimate 0.35 · Beat by 41.88%
EPS: actual versus estimate
Recent quarterly results
Revenue: actual versus estimate
Recent quarterly results
Analyst ratings
Third-party consensus; not a GoAI recommendation.
Analyst price target
Average target
$46.33
35.23% upsideMDLN news
MDLN peers
ETFs holding MDLN
Funds reporting this stock among their holdings, ordered by reported position size.
Vanguard Morningstar Total Stock Market ETFVTI488.9M0.02%2.3T USD0.03%$378.24+0.44%
Vanguard Morningstar Mid-Cap ETFVO332.19M0.15%224.7B USD0.03%$82.97+0.53%
Vanguard Extended Market ETFVXF182.11M0.19%93.7B USD0.05%$245.53+0.82%
Vanguard Morningstar Value ETFVTV146.29M0.06%256.5B USD0.03%$226.4+0.54%
Vanguard Morningstar Mid-Cap Value ETFVOE98.81M0.25%38.6B USD0.05%$208.64+0.35%
iShares Russell Mid-Cap ETFIWR59.52M0.10%57.66B USD0.18%$113.44+0.70%
Vanguard Health Care ETFVHT44.09M0.21%20.9B USD0.09%$327.7+1.24%
First Trust US Equity Opportunities ETFFPX34.92M2.32%1.51B USD0.57%$183.88+0.42%
Vanguard Morningstar Total Stock Market ETFVTI- Market value
- 488.9M
- Weight
- 0.02%
- AUM
- 2.3T USD
- Expense ratio
- 0.03%
- Price / 1D
- $378.24+0.44%
Vanguard Morningstar Mid-Cap ETFVO- Market value
- 332.19M
- Weight
- 0.15%
- AUM
- 224.7B USD
- Expense ratio
- 0.03%
- Price / 1D
- $82.97+0.53%
Vanguard Extended Market ETFVXF- Market value
- 182.11M
- Weight
- 0.19%
- AUM
- 93.7B USD
- Expense ratio
- 0.05%
- Price / 1D
- $245.53+0.82%
Vanguard Morningstar Value ETFVTV- Market value
- 146.29M
- Weight
- 0.06%
- AUM
- 256.5B USD
- Expense ratio
- 0.03%
- Price / 1D
- $226.4+0.54%
Vanguard Morningstar Mid-Cap Value ETFVOE- Market value
- 98.81M
- Weight
- 0.25%
- AUM
- 38.6B USD
- Expense ratio
- 0.05%
- Price / 1D
- $208.64+0.35%
iShares Russell Mid-Cap ETFIWR- Market value
- 59.52M
- Weight
- 0.10%
- AUM
- 57.66B USD
- Expense ratio
- 0.18%
- Price / 1D
- $113.44+0.70%
Vanguard Health Care ETFVHT- Market value
- 44.09M
- Weight
- 0.21%
- AUM
- 20.9B USD
- Expense ratio
- 0.09%
- Price / 1D
- $327.7+1.24%
First Trust US Equity Opportunities ETFFPX- Market value
- 34.92M
- Weight
- 2.32%
- AUM
- 1.51B USD
- Expense ratio
- 0.57%
- Price / 1D
- $183.88+0.42%
Continue in GoAI
Research MDLNresearch.disclaimer











